Jump to content

pSivida

From Wikipedia, the free encyclopedia


pSivida Corp.
Company typePublic company
NasdaqPSDV ASXPVA FWBPV3
IndustryPharmaceuticals
Headquarters,
Number of locations
2
ProductsIluvien
Websitewww.psivida.com

EyePoint Pharmaceuticals, Inc. (formerly pSivida Corp.) pSivida is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.

pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency (DERA, now QinetiQ).[citation needed] QinetiQ continues to be a strategic partner.[1][2]

In June 2004, pSivida acquired full ownership of pSiMedica.[1] In April 2018, pSivida purchased eye products firm Icon Bioscience.[3][4]

See also

[edit]

References

[edit]
  1. ^ a b "PSivida lifts pSiMedica stake to 100%". The Sydney Morning Herald. 2004-06-02. Retrieved 2020-10-29.
  2. ^ "Nano silicon boosts tumour fight". 2004-06-18. Retrieved 2020-10-29.
  3. ^ "BRIEF—pSivida to buy eye products firm Icon Bioscience". The Pharma Letter. Retrieved 2018-06-22.
  4. ^ "BRIEF-pSivida Corp Announces Transformative Acquisition Of Icon Bioscience". Reuters. 2018-03-28. Retrieved 2020-10-29.
[edit]